SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Sihuan Pharmaceutical Holdings Group Ltd. SHPHF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • HK • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.19. It has a SharesGrow Score of 33/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $1.9B, -13.6%/yr average growth. Net income is $217M (loss), growing at -257.4%/yr. Net profit margin is -11.4% (negative). Gross margin is 65.3% (-14.7 pp trend).

Balance sheet: total debt is $974M against $4.4B equity (Debt-to-Equity (D/E) ratio 0.22, conservative). Current ratio is 1.73 (strong liquidity). Debt-to-assets is 9.2%. Total assets: $10.5B.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 67/100 (Partial), Moat 59/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

SHPHF SharesGrow Score Overview

35/100

SharesGrow Score

Below average — proceed with caution

View full scorecard →

VALUE 0/100

Valuation — P/E, PEG, Forward PEG

GROWTH 15/100

Financials — average growth

PAST 25/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 59/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 10/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SHPHF

No analyst coverage available for this stock.

SHPHF: -13.6%/yr revenue is, -257.4%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SHPHF: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SHPHF: Debt-to-Equity (D/E) ratio 0.22 (conservative), Current ratio is 1.73 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SHPHF: Gross margin is 65.3% (-14.7 pp trend), $2B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 59/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

SHPHF: Net profit margin is -11.4%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.0492-0.2103

Volume300

Avg Volume (30D)1.66K

Market Cap$1.71B

Beta (1Y)1.13

Dividend Yield$0.0027

Share Statistics

EPS (TTM)-0.02

Shares Outstanding$9.27B

IPO Date2012-01-13

Employees2,667

CEOWeicheng Guo

Financial Highlights & Ratios

Revenue (TTM)$1.9B

Gross Profit$1.24B

EBITDA$105.07M

Net Income$-216.66M

Operating Income$-138.13M

Total Cash$3.88B

Total Debt$974.01M

Net Debt$-2.65B

Total Assets$10.53B

Price / Earnings (P/E)-8

Price / Sales (P/S)0.9

Analyst Forecast

Company Info

CountryHK

ExchangeOther OTC

CurrencyUSD

ISINBMG8162K1137

Price Chart

SHPHF

Sihuan Pharmaceutical Holdings Group Ltd. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

0.05 52WK RANGE 0.21

People Also View

Phibro Animal Health Corporation

Cronos Group Inc.

Canopy Growth Corporation

Aquestive Therapeutics, Inc.

Aurora Cannabis Inc.

Organigram Global Inc.

Lifecore Biomedical, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message